Illuminating the Path for Novel Peripheral Drug-Eluting Stents
- PMID: 35219619
- PMCID: PMC12695620
- DOI: 10.1016/j.jcin.2022.01.022
Illuminating the Path for Novel Peripheral Drug-Eluting Stents
Keywords: clinical trials; drug-eluting stent(s); peripheral vascular disease.
Conflict of interest statement
Funding Support and Author Disclosures Dr Secemsky is funded by National Institutes of Health/National Heart, Lung, and Blood Institute grant K23HL150290. He also receives funding support from the Food & Drug Administration, Harvard Medical School’s Shore Faculty Development Award, AstraZeneca, BD, Boston Scientific, Cook, CSI, Laminate Medical, Medtronic and Philips; and consults for Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Endovascular Engineering, Inari, Janssen, Medtronic, Philips, and VentureMed. Dr Kochar has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
2-Year Results With a Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions: The First-in-Human ILLUMINA Study.JACC Cardiovasc Interv. 2022 Mar 28;15(6):618-626. doi: 10.1016/j.jcin.2021.12.034. Epub 2022 Feb 23. JACC Cardiovasc Interv. 2022. PMID: 35219622
References
-
- Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J. 2018;39(9):763–816. 10.1093/eurheartj/ehx095 - DOI - PubMed
-
- Bradbury AW, Adam DJ, Bell J, et al. , BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(5 Suppl):5S–17S. 10.1016/j.jvs.2010.01.073 - DOI - PubMed
-
- Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G, VIVA Physicians. Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69(6):910–919. 10.1002/ccd.21104 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
